(Q37832037)

24 August 2017

1 reference

title

New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications (English)

1 reference

24 August 2017

0 references

Asif Ahmed

1

1 reference

24 August 2017

publication date

1 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

127 Suppl 3

1 reference

24 August 2017

page(s)

S72-5

1 reference

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Soluble endoglin contributes to the pathogenesis of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Endoglin regulates nitric oxide-dependent vasodilatation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Adverse pregnancy outcomes in snuff users

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Heme oxygenase-1 protects against vascular constriction and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

A novel strategy against ischemia and reperfusion injury: cytoprotection with heme oxygenase system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Effect of cigarette smoke on placental antioxidant enzyme expression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Risk of congenital anomalies in pregnant users of statin drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2811%2970020-2

7 January 2021

10.1016/S0049-3848(11)70020-2

Identifiers

DOI

1 reference

24 August 2017

1 reference